Video

Associating Genes With Melanoma Risk

Author(s):

Maria T. Landi, M.D., Ph.D.
Conference|World Congress on Melanoma

Maria T. Landi, M.D., Ph.D., principal investigator at the National Cancer Institute (NCI) and National Institutes of Health (NIH) discusses a recent study that identified genetic variations that may be linked with increased melanoma risk.

Maria T. Landi, M.D., Ph.D., principal investigator at the National Cancer Institute (NCI) and National Institutes of Health (NIH) discusses a recent study that identified genetic variations that may be linked with increased melanoma risk.

The large, meta-analysis observed 27,000 patients with melanoma and 50,000 controls from the United States, Australia and Europe and discovered 19 additional genes that showed a strong correlation with melanoma risk. Included were alterations in pigmentation pathways, telomeres, immunity and signalisn and transcription pathways.

In the future, Landi and her research team will be adding about 10,000 more patients to hopefully identify more genetic associations with melanoma.

Related Videos
Image of a man in a suit.
Image of woman with brown hair.
Image of a man with short black hair.
Image of a woman with wavy blonde hair wearing glasses.
Image of man with black hair.
Image of a woman with layered hair, wearing a bright blue cardigan.
Image of a man with short black hair.
Image of man with gray hair.
Image of woman with black hair.
Related Content
Image of COVID-19 cells.
November 18th 2024

COVID-19 RNA May Be Linked to Metastatic Cancer Regression

Ashley Chan
RNA from the COVID-19 infection in patients with certain metastatic cancers may be associated with tumor shrinkage, but more research is necessary.
CURE Cancer Horizons logo
February 26th 2024

FDA Approvals from February 2024

Alex Biese Brielle Benyon
February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.
"FDA" text.
November 9th 2024

FDA Approves MI Cancer Seek as Companion Diagnostic for Adult and Pediatric Patients With Cancer

Ryan Scott
MI Cancer Seek has received approval from the FDA as a companion diagnostic test to identify those who may benefit from treatment with targeted therapies.
Top Cancer Headlines from 2023
January 2nd 2024

Top Cancer Headlines from 2023

Alex Biese Brielle Benyon
From Jimmy Buffett's death to the chemo shortage and cannabis use in cancer care, here is a look back at some of our most popular oncology stories from 2023.
Image of a doctor examining a patient's skin.
November 4th 2024

Early Data Show Benefits With Ameluz-Photodynamic Therapy in Skin Cancer Subset

Darlene Dobkowski, MA
Ameluz-photodynamic therapy in superficial basal cell carcinoma may improve the clearance of target lesions, as shown in early data from a phase 3 trial.
Image of camera taking picture of skin.
October 31st 2024

Opdivo and Yervoy May Improve Survival for Resected Stage 3/4 Melanoma

Spencer Feldman
Patients with resected stage 3 or 4 melanoma treated with immune-oncology agents demonstrated significantly higher cure rates compared to those treated with placebo.